Targeted cancer treatment program optimization
Part of Cancer clinical trials.
This study looks at how to improve targeted cancer treatments—therapies designed to attack specific features of a cancer. If your doctor has already prescribed a targeted therapy for you, the trial may be looking at how to use it more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer and your doctor prescribed a targeted cancer medicine for you
- You are able to understand and make decisions about the study
- You are not under legal protection or guardianship for decision-making
- You are judged capable of participating and following study instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research program studies solid tumors to find better treatments. It collects health data to help develop personalized cancer care.
This trial tests a program to help teenagers and young adults take their oral cancer medications as prescribed. It aims to make medication routines easier and improve adherence.
This early-phase study tests whether a personalized cancer treatment plan based on your tumor’s test results can help people with aggressive cancers that are hard to treat. It may be an option if standard treatments didn’t work, aren’t possible for you, or you have few treatment choices.
This study looks at how “precision medicine” testing on your tumor (or planning to do it) can help guide possible targeted treatments for advanced cancer. It is observational, meaning researchers mainly watch and record what happens as testing results become available.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
This Phase 2 trial matches people with advanced cancer to a targeted treatment based on a genetic (DNA) or protein (IHC) test from their tumor. It’s for cancers that are no longer responding to standard treatment or where no standard option is available.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.